Latest filing published 02 Oct 2014 for KYTO BIOPHARMA INC.
No signal scores available.
Filings by Medarex Inc span 2 companies, the busiest being Celldex Therapeutics, Inc. and Kyto Biopharma Inc. Over a trading history stretching from 23 June 2008 to 30 September 2014, the count stands at 3 filings.
The open-market record consists of 2 sales worth €13.0M, with no purchase.
The latest filing, published on 2 October 2014, reports a transaction in Kyto Biopharma Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations